CDSCO Panel Approves Pfizer Protocol Amendment proposal to study anti-cancer drug Elranatamab Dr. Divya Colin4 Nov 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
JnJ seeks USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma patients for whom transplant is not planned Ruchika Sharma6 Oct 2024 10:30 AM ISTRaritan: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
CDSCO Panel grants GSK's Protocol Amendment Proposal To Study Belantamab mafodotin Dr. Divya Colin1 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
USFDA nod to Sanofi Sarclisa in combo with bortezomib, lenalidomide, dexamethasone for newly diagnosed multiple myeloma not eligible for transpant Ruchika Sharma21 Sept 2024 2:25 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Sarclisa (isatuximab) in combination with bortezomib,...
Cancer drug may be repurposed for hereditary bleeding disorder, reveals clinical trial Dr. Kamal Kant Kohli20 Sept 2024 4:00 AM ISTA drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare...
Lupin unveils generic cancer drug in US Ruchika Sharma30 Aug 2024 1:00 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50...
Shilpa Medicare gets USFDA nod for Bortezomib Injection for multiple myeloma Ruchika Sharma28 Aug 2024 11:57 AM ISTKarnataka: Shilpa Medicare Ltd has announced the U.S. Food and Food Administration (USFDA) has approved the Company's second NDA...
Bristol Myers Squibb India Gets CDSCO Panel Nod to Study anticancer drug Mezigdomide Dr. Divya Colin17 Aug 2024 6:00 PM ISTNew Delhi: The drug major Bristol-Myers Squib has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
JnJ gets USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma who are transplant-eligible Ruchika Sharma2 Aug 2024 11:30 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved DARZALEX FASPRO (daratumumab and...
Blood proteins predict the risk of developing more than 60 diseases, claims study Dr. Kamal Kant Kohli25 July 2024 3:30 AM ISTResearch on thousands of proteins measured from a drop of blood demonstrates the ability of proteins to predict the onset of many diverse diseases. ...
Lupin alliance partner ForDoz gets USFDA nod for Doxorubicin Hydrochloride Liposome Injection Ruchika Sharma23 July 2024 1:20 PM ISTMumbai: Global pharma major Lupin Limited has announced that its alliance partner, ForDoz Pharma Corporation, USA has received approval from the...
Blenrep combinations in multiple myeloma application accepted for review by EMA: GSK Ruchika Sharma20 July 2024 3:30 PM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the marketing authorisation application (MAA) for...
